Södertälje, Sweden

Lorenz M Mayr

This inventor holds 3 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2021-2025.


% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lorenz M Mayr: Innovator in Gene Modification

Introduction

Lorenz M Mayr is a prominent inventor based in Södertälje, Sweden. He has made significant contributions to the field of gene modification, holding a total of 3 patents. His work focuses on developing innovative tools for high-throughput functional genomics studies.

Latest Patents

One of his latest patents is titled "Inducible Modification of a Cell Genome." This patent encompasses gene modification assays that provide nucleic acid-based tools for generating knockout or knockin cell lines. The tools include an 'activatable reporter cassette,' a guide RNA construct, and a nuclease that can be utilized together to modify and isolate targeted cells of interest.

Career Highlights

Lorenz M Mayr is currently associated with AstraZeneca AB, where he continues to advance research in gene modification. His expertise in this area has positioned him as a key figure in the development of innovative genomic tools.

Collaborations

He has collaborated with notable coworkers, including Marcello Maresca and Mohammad Bohlooly-Yeganeh, contributing to various projects that enhance the understanding and application of gene modification techniques.

Conclusion

Lorenz M Mayr's work in gene modification exemplifies the innovative spirit of modern science. His patents and collaborations reflect a commitment to advancing the field of genomics, making significant strides in the development of new technologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…